Tafluprost
- Generic Name
- Tafluprost
- Brand Names
- Zioptan
- Drug Type
- Small Molecule
- Chemical Formula
- C25H34F2O5
- CAS Number
- 209860-87-7
- Unique Ingredient Identifier
- 1O6WQ6T7G3
- Background
A prostaglandin analogue ester prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. Chemically, tafluprost is a fluorinated analog of prostaglandin F2-alpha. Tafluprost was approved for use in the U.S. on February 10, 2012.
- Indication
Tafluprost is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
- Associated Conditions
- Increased Intra Ocular Pressure (IOP), Ocular Hypertension
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath